In a laboratory in Texas, chicks hatched from an egg that never came from a chicken—or any bird at all. Colossal Biosciences, a de-extinction company, announced this week that it has successfully created an artificial egg that supports the full development of bird embryos without a biological eggshell and without requiring supplemental oxygen. If verified, the innovation could reshape conservation efforts for critically endangered species worldwide, though questions linger about the company's ability to deliver on its most ambitious claims.
The achievement matters because artificial egg technology addresses one of nature's stubborn limitations: many endangered bird species are slow breeders that produce few eggs, making captive breeding programs painfully inefficient. Scientists have been experimenting with artificial eggs since the 1980s, growing embryos outside shells for research purposes, but they've always faced a critical problem. To improve hatching rates, the embryos needed direct infusions of pure oxygen—yet that same oxygen can damage the developing chick. Colossal says it has solved this puzzle with a design centered on an open, latticed half-shell and a transparent, silicone-based membrane that allows oxygen to diffuse naturally from the air into the developing embryo.
The company's vision extends far beyond chickens. Colossal plans to genetically modify an emu genome to resemble that of a giant moa, create an embryo inside an emu egg, and then bring it to term using its artificial incubator. The same technology could support attempts to resurrect the dodo by engineering a Nicobar pigeon. Yet the source material raises a crucial caveat: a giant moa egg would have been up to 80 times larger than a chicken egg, and an egg yolk is a single cell. It remains unclear whether scientists can simply enlarge natural yolk to match such colossal proportions without compromising the embryo's survival.
For living species in crisis, the potential is more immediate. Captive breeding programs for critically endangered birds like the kākāpō, kakī black stilt, and pukunui southern dotterel could use artificial eggs to rescue damaged eggs or dramatically expand breeding capacity. Combined with genetic engineering, the technology could reintroduce lost genetic diversity or breed disease resistance into vulnerable populations. In essence, it could transform eggs damaged by inexperienced parents, weather, or accident into viable chicks.
But Colossal's announcement carries a significant caveat: the company released no peer-reviewed data or scientific publications alongside its slick promotional video. Without independent verification, researchers cannot assess whether the claims hold up to scrutiny. Bird embryo development is fiendishly complex and species-specific; what works for chickens may not translate to emus or pigeons.
The company has mobilized substantial private funding for this work—capital that would likely never have reached conservation efforts otherwise. Yet that same ambition comes with baggage. The Māori people of New Zealand have expressed widespread opposition to Colossal's plans for a moa de-extinction ecotourism venture, raising questions about who decides which species should be resurrected and for whom.
The artificial egg represents genuine scientific innovation with real applications for saving living species from extinction. Whether it also becomes a tool for bringing back the dead remains an open question.